Glaucoma News

January is National Glaucoma Awareness Month, a time to spread awareness about a disease that accounts for 9% to 12% of all cases of blindness in the U.S., according to the Glaucoma Research Foundation.

Five Medicare Administrative Contractors have withdrawn their final local coverage determinations for micro-invasive glaucoma surgery that were scheduled to take effect on Jan. 29, 2024, according to a press release from Sight Sciences.

NEW ORLEANS — M&S Technologies has incorporated SmarTracker 2 technology into its Smart System VR headset to improve patient fixation during visual field testing, Mike Umali, national sales manager for M&S Technologies, said at Academy ’23.

Throughout the year, Healio publishes a host of blogs on topics ranging from common conditions like keratoconus and glaucoma to crossover care that includes concussion management and diseases of the brain.

Nicox announced that the first patient has been screened in its Whistler phase 3b clinical trial of NCX 470, a nitric oxide-donating bimatoprost eye drop designed to lower IOP in patients with open-angle glaucoma or ocular hypertension.

Therapies for treating glaucoma, including doxycycline and blue-light filtering IOLs, made top headlines this year in optometry news.

As IOP decreases throughout the day, it is essential for clinicians to evaluate both morning and evening values to effectively monitor IOP-related diseases, according to research published in Cureus.

The self-measurement iCare Home2 tonometer may be reliable for most eyes and clinical settings, although central corneal thickness measurements are recommended before use, according to research published in the Journal of Glaucoma.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Renee Bovelle, MD, discusses real-world insights on the use of Dextenza.

Patients with open-angle glaucoma who abstain from consuming alcohol may be at lower risk for severe visual impairment and blindness, according to a review published in JAMA Network Open.